Xtant(TM) Medical awarded grant from Montana Board of Research and Commercialization
Xtant Medical announced, its wholly owned subsidiary, Bacterin International, has been awarded a grant from the Montana Board of Research and Commercialization Technology in the amount of $100,000 for the development and commercialization of the next generation of DBM allografts. October 06, 2015